(Q28211766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

3

Elias Perentes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

5

Daniel Roth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Gerda Andringa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Silvia Eshuis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Merdol Ibrahim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Klaus L Leenders

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Alexander R Cools

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

published in

Neurobiology of Disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

205-217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Programmed cell death: does it play a role in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Increased dopamine clearance in the non-lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Central Monoamine Metabolism in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

A role for GAPDH in apoptosis and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Selegiline-induced postural hypotension in Parkinson's disease: a longitudinal study on the effects of drug withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Positron emission tomography with 18F-DOPA: Interpretation and biological correlates in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

PET studies of functional compensation in a primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Neuronal sparing and behavioral effects of the antiapoptotic drug, (-)deprenyl, following kainic acid administration

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by postiron emission tomography and whole body autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Mechanism and consequences of nerve cell death in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine to monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Pheochromocytomas and ganglioneuromas in the aging rats: morphological and immunohistochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Developing a stable bilateral model of parkinsonism in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900125-6

7 January 2021

10.1016/S0969-9961(03)00125-6

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017